Substrate specificity of homogeneous monkeypox virus uracil-DNA glycosylase

Biochemistry

Volumn 46, Issue 42, 2007, Pages 11874-11881

  Duraffour, Sophie ^a   Ishchenko, Alexander A ^b   Saparbaev, Murat ^b   Crance, Jean Marc ^a   Garin, Daniel ^c  

^a Centre de Recherches du Service de Sante des Armees   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC MODIFICATIONS; MONKEYPOX VIRUSES; POXVIRUSES; SUBSTRATE SPECIFICITY;

DNA; DRUG PRODUCTS; ENZYME INHIBITION; PATHOGENS; VIRUSES;

ENZYME KINETICS;

4 AMINOURACIL; 5 AZAURACIL; ADENINE; DNA BASE; GUANINE; MAGNESIUM CHLORIDE; SINGLE STRANDED DNA; SODIUM CHLORIDE; UNCLASSIFIED DRUG; URACIL; URACIL DERIVATIVE; URACIL DNA GLYCOSIDASE; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; DNA MODIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; MONKEYPOX VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SMALLPOX; VIRUS PATHOGENESIS;

ANIMALS; BASE PAIRING; BASE SEQUENCE; DNA; DNA, SINGLE-STRANDED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; HISTIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; ISOENZYMES; KINETICS; MAGNESIUM CHLORIDE; MONKEYPOX VIRUS; PLASMIDS; RECOMBINANT PROTEINS; SODIUM CHLORIDE; SUBSTRATE SPECIFICITY; TRANSFECTION; URACIL; URACIL-DNA GLYCOSIDASE; VACCINIA VIRUS; VIRAL PROTEINS;

MONKEYPOX VIRUS; POXVIRIDAE; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 35448936117     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700726a     Document Type: Article

References (36)

1. Di Giulio, D. B., and Eckburg, P. B. (2004) Human monkeypox: An emerging zoonosis, Lancet Infect. Dis. 4, 15-25.
2. Hutin, Y. J., Williams, R. J., Malfait, P., Pebody, R., Loparev, V. N., Ropp, S. L., Rodriguez, M., Knight, J. C., Tshioko, F. K., Khan, A. S., Szczeniowski, M. V., and Esposito, J. J. (2001) Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997, Emerg. Infect. Dis. 7, 434-438.
3. Learned, L. A., Reynolds, M. G., Wassa, D. W., Li, Y., Olson, V. A., Karem, K., Stempora, L. L., Braden, Z. H., Kline, R., Likos, A., Libama, F., Moudzeo, H., Bolanda, J. D., Tarangonia, P., Boumandoki, P., Formenty, P., Harvey, J. M., and Damon, I. K. (2005) Extended Interhuman Transmission of Monkeypox in a Hospital Community in the Republic of the Congo, 2003, Am. J. Trop. Med. Hyg. 73, 428-434.
4. De Silva, F. S., and Moss, B. (2003) Vaccinia virus uracil DNA glycosylase has an essential role in DNA synthesis that is independent of its glycosylase activity: Catalytic site mutations reduce virulence but not virus replication in cultured cells, J. Virol. 77, 159-166.
5. Krokan, H. E., Drablos, F., and Slupphaug, G. (2002) Uracil in DNA: Occurrence, consequences and repair, Oncogene 21, 8935-8948.
6. Leblanc, J. P., and Laval, J. (1982) Comparison at the molecular level of uracil-DNA glycosylases from different origins, Biochimie 64, 735-738.
7. Kavli, B., Sundheim, O., Akbari, M., Otterlei, M., Nilsen, H., Skorpen, F., Aas, P. A., Hagen, L., Krokan, H. E., and Slupphaug, G. (2002) hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup, J. Biol. Chem. 277, 39926-39936.
8. Slupphaug, G., Markussen, F. H., Olsen, L. C., Aasland, R., Aarsaether, N., Bakke, O., Krokan, H. E., and Helland, D. E. (1993) Nuclear and mitochondrial forms of human uracil-DNA glycosylase are encoded by the same gene, Nucleic Acids Res. 21, 2579-2584.
9. Slupphaug, G., Eftedal, I., Kavli, B., Bharati, S., Helle, N. M., Haug, T., Levine, D. W., and Krokan, H. E. (1995) Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UNG encodes the major uracil-DNA glycosylase, Biochemistry 34, 128-138.
10. Mol, C. D., Arvai, A. S., Sanderson, R. J., Slupphaug, G., Kavli, B., Krokan, H. E., Mosbaugh, D. W., and Tainer, J. A. (1995) Crystal stmcture of human uracil-DNA glycosylase in complex with a protein inhibitor: Protein mimicry of DNA, Cell 82, 701-708.
11. Mol, C. D., Arvai, A. S., Slupphaug, G., Kavli, B., Alseth, I., Krokan, H. E., and Tainer, J. A. (1995) Crystal structure and mutational analysis of human uracil-DNA glycosylase: Structural basis for specificity and catalysis, Cell 80, 869-878.
12. Parikh, S. S., Mol, C. D., Slupphaug, G., Bharati, S., Krokan, H. E., and Tainer, J. A. (1998) Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA, EMBO J. 17, 5214-5226.
13. Slupphaug, G., Mol, C. D., Kavli, B., Arvai, A. S., Krokan, H. E., and Tainer, J. A. (1996) A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA, Nature 384, 87-92.
14. Scaramozzino, N., Sanz, G., Crance, J. M., Saparbaev, M., Drillien, R., Laval, J., Kavli, B., and Garin, D. (2003) Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylase, Nucleic Acids Res. 31, 4950-4957.
15. Caradonna, S., Worrad, D., and Lirette, R. (1987) Isolation of a herpes simplex virus cDNA encoding the DNA repair enzyme uracil-DNA glycosylase, J. Virol. 61, 3040-3047.
16. Upton, C., Stuart, D. T., and McFadden, G. (1993) Identification of a poxvirus gene encoding a uracil DNA glycosylase, Proc. Natl. Acad. Sci. U.S.A. 90, 4518-4522.
17. Moss, B. (1990) Poxviridae and their replication, in Virology (Fields, B. N., and Knipe, D. M., Eds.) pp 2079-2111, Raven Press, New York.
18. Ishii, K., and Moss, B. (2001) Role of vaccinia virus A20R protein in DNA replication: Construction and characterization of temperature-sensitive mutants, J. Virol. 75, 1656-1663.
19. Ishii, K., and Moss, B. (2002) Mapping interaction sites of the A20R protein component of the vaccinia virus DNA replication complex, Virology 303, 232-239.
20. Traktman, P. (1996) Poxviridae DNA replication, in DNA replication in eukariotic cells (DePamphilis, M., Ed.) pp 775-798, Cold Spring Harbor Laboratory Press, Plainview, NY.
21. Stanitsa, E. S., Arps, L., and Traktman, P. (2006) The vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase, J. Biol. Chem. 281, 3439-3451.
22. Massung, R. F., Esposito, J. J., Liu, L. I., Qi, J., Utterback, T. R., Knight, J. C., Aubin, L., Yuran, T. E., Parsons, J. M., Loparev, V. N., et al. (1993) Potential virulence determinants in terminal regions of variola smallpox virus genome, Nature 366, 748-751.
23. Shchelkunov, S. N., Totmenin, A. V., Safronov, P. F., Mikheev, M. V., Gutorov, V. V., Ryazankina, O. I., Petrov, N. A., Babkin, I. V., Uvarova, E. A., Sandakhchiev, L. S., Sisler, J. R., Esposito, J. J., Damon, I. K., Jahrling, P. B., and Moss, B. (2002) Analysis of the monkeypox virus genome, Virology 297, 172-194.
24. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P., and Paoletti, E. (1990) The complete DNA sequence of vaccinia virus, Virology 179, 247-266.
25. Ellison, K. S., Peng, W., and McFadden, G. (1996) Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability, J. Virol. 70, 7965-7973.
26. Krokan, H., and Wittwer, C. U. (1981) Uracil DNA-glycosylase from HeLa cells: General properties, substrate specificity and effect of uracil analogs, Nucleic Acids Res. 9, 2599-2613.
27. Focher, F., Verri, A., Spadari, S., Manservigi, R., Gambino, J., and Wright, G. E. (1993) Herpes simplex virus type 1 uracil-DNA glycosylase: Isolation and selective inhibition by novel uracil derivatives, Biochem. J. 292 (Part 3), 883-889.
28. Maksimenko, A., Ishchenko, A. A., Sanz, G., Laval, J., Elder, R. H., and Saparbaev, M. K. (2004) A molecular beacon assay for measuring base excision repair activities, Biochem. Biophys. Res. Commun. 319, 240-246.
29. De Clercq, E. (2001) Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections, Clin. Microbiol. Rev. 14, 382-397.
30. De Clercq, E. (2002) Cidofovir in the treatment of poxvirus infections, Antiviral Res. 55, 1-13.
31. Quenelle, D. C., Buller, R. M., Parker, S., Keith, K. A., Hruby, D. E., Jordan, R., and Kern, E. R. (2006) Efficacy of Delayed Treatment of ST-246 Given Orally Against Systemic Orthopox-virus Infections in Mice, Antimicrob. Agents Chemother. 51, 689-695.
32. Yang, G., Pevear, D. C., Davies, M. H., Collett, M. S., Bailey, T., Rippen, S., Barone, L., Burns, C., Rhodes, G., Tohan, S., Huggins, J. W., Baker, R. O., Buller, R. L., Touchette, E., Waller, K., Schriewer, J., Neyts, J., Declercq, E., Jones, K., Hruby, D., and Jordan, R. (2005) An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge, J. Virol. 79, 13139-13149.
33. LeDuc, J. W., Damon, I., Relman, D. A., Huggins, J., and Jahrling, P. B. (2002) Smallpox research activities: U.S. Interagency collaboration, 2001, Emerg. Infect. Dis. 8, 743-745.
34. Advisory Committee on variola virus research: Report of the seventh meeting (2005) WHO/CDS/EPR/2006.2, pp 1-21.
35. Pearl, L. H. (2000) Structure and function in the uracil-DNA glycosylase superfamily, Mutat. Res. 460, 165-181.
36. Schorman, N., Grigorian, A., Samal, A., Krishnan, R., Delucas, L., and Chattopadhyay, D. (2007) Crystal stmcture of vaccinia virus uracil-DNA glycosylase reveals dimeric assembly, BMC Struct. Biol. 7, 45.